Apimeds Pharmaceuticals US (APUS) Enterprise Value (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Enterprise Value came in at -$9.6 million in Q4 2025, down 278819.1% YoY from N/an in Q4 2024, and down 37.93% on a QoQ basis from -$7.0 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Enterprise Value (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Enterprise Value data on file, last reported at -$9.6 million in Q4 2025.
- Quarterly Enterprise Value fell 278819.1% year-over-year to -$9.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.6 million (down 278819.1% YoY) and the FY2025 annual result came in at -$9.6 million, down 278819.1% from the prior year.
- Enterprise Value slipped to -$9.6 million in Q4 2025, from -$7.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3455.0 in Q4 2024 to a low of -$9.6 million in Q4 2025.
- A 3-year average of -$4.3 million and a median of -$3.7 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value soared 99.16% — and 2025, when it plunged 278819.1%.
- Tracing APUS's Enterprise Value over 3 years: stood at -$410481.0 in 2023, then soared by 99.16% to -$3455.0 in 2024, then sank by 278819.1% to -$9.6 million in 2025.
- The last three Enterprise Value figures came in at -$9.6 million (Q4 2025), -$7.0 million (Q3 2025), and -$8.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 7.20 Mn | 7.20 Mn | - | -124.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.64 Mn |
| Sep 30, 2025 | -6.99 Mn |
| Jun 30, 2025 | -8.74 Mn |
| Mar 31, 2025 | -250,342.00 |
| Dec 31, 2024 | -3,455.00 |
| Dec 31, 2023 | -410,481.00 |